Journals in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

Books Journals

11-20 of 42 results in All results

Contraception

ISSN: 0010-7824
5 Year impact factor: 2.7
Impact factor: 2.8

An international reproductive health journal The Official Journal of the Society of Family PlanningThe journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Current Opinion in Pharmacology

ISSN: 1471-4892
5 Year impact factor: 4.1
Impact factor: 4

Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.COPHAR is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Pharmacology and Drug Discovery (CRPHAR) .COPHAR divides the subject of pharmacology into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance. Themes include neurosciences; cardiovascular and renal; respiratory; musculoskeletal; cancer; immunomodulation; anti-infectives; new technologies; gastrointestinal; endocrine; and metabolic diseases.The journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.Expertise - Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.Comprehensiveness - There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.Impact - In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Reviews Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier.com/conflictsofinterest

Currents in Pharmacy Teaching and Learning

ISSN: 1877-1297
5 Year impact factor: 1.7
Impact factor: 1.3

Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricular outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/perceptions within pharmacy education

Environmental Toxicology and Pharmacology

ISSN: 1382-6689
5 Year impact factor: 4.4
Impact factor: 4.2

Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

European Journal of Cancer

ISSN: 0959-8049
5 Year impact factor: 7.7
Impact factor: 7.6

Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

European Journal of Pharmaceutics and Biopharmaceutics

ISSN: 0939-6411
5 Year impact factor: 4.8
Impact factor: 4.4

Official Journal of the International Association for Pharmaceutical TechnologyThe European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.Topics covered include for example:Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)Aspects of manufacturing process designBiomedical aspects of drug product designStrategies and formulations for controlled drug transport across biological barriersPhysicochemical aspects of drug product developmentNovel excipients for drug product designDrug delivery and controlled release systems for systemic and local applicationsNanomaterials for therapeutic and diagnostic purposesAdvanced therapy medicinal productsMedical devices supporting a distinct pharmacological effect"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: 1. The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance. 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented. 3. The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.

European Journal of Pharmaceutics and Biopharmaceutics

European Journal of Pharmacology

ISSN: 0014-2999
5 Year impact factor: 4.3
Impact factor: 4.2

The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.The scope includes: Behavioural pharmacology, Neuropharmacology and psychopharmacology, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, Molecular and cellular pharmacology, Regenerative pharmacology, Biologicals and biotherapeutics, Translational pharmacology and Nutriceutical pharmacology.The journal publishes full-length papers and reviews. Ethnopharmacological studies with plant extracts or mixtures are not in scope of this journal.The table of contents for this journal is now available pre-publication, via e-mail, as part of the free ContentsDirect service from Elsevier. Please send an e-mail message to [email protected] for further information about this service.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

European Neuropsychopharmacology

ISSN: 0924-977X
5 Year impact factor: 5.3
Impact factor: 6.1

An Official Journal of the European College of Neuropsychopharmacology European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology (ECNP).Electronic usage: An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Average monthly article downloads for this journal: 29,000

Fitoterapia

ISSN: 0367-326X
5 Year impact factor: 2.7
Impact factor: 2.5

The Journal for the Study of Medicinal PlantsFitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in seven major areas:1. Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes 2. New analytical approaches for dereplication and standardization of biologically active extracts and metabolites from plant resources 3. Identification of bioactivity in plant and fungal extracts and in their constituents 4. Identification of biological targets and mechanism of activity of plant and fungal extracts 5. Production and genomic characterization of medicinal plants biomass 6. Biosynthesis of bioactive natural products of plant, fungi and endophytic origin 7. Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues.Contributions reporting the following are NOT normally considered for publication: 1. Activity data on crude extracts that have not been characterized by analysis of their major constituents (HPLC fingerprint, LC/MS or NMR). Data on the extract composition simply taken from the literature are not acceptable. Characterization of only a few constituents is generally considered too partial. 2. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. 3. Unexceptional and predictable bioactivity (e.g. antioxidant properties of phenolics or antibacterial activity of essential oils). 4. Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. 5. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal. RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified, authenticated, and documented (voucher). RULE 4: Characterization of new compounds without spectral supporting material. RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature.

Free Radical Biology & Medicine

ISSN: 0891-5849
5 Year impact factor: 7.9
Impact factor: 7.1

An official JOURNAL of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe; affiliate journal of the International Society for Free Radical Research (SFRRI)Free Radical Biology and Medicine is the premier forum for publishing ground-breaking research in the redox biology of both health and disease. We focus on signal transduction and redox signaling; oxidative stress; reductive stress; redox stress; nitrosative stress; aging and age-related diseases; redox biology in skeletal and cardiac muscle, exercise science, and sports medicine; metabolic regulation and metabolic diseases; mitochondrial function and signaling; homeostatic mechanisms and adaptive responses; redox chemistry and mechanisms; materials and nanomaterials; non-thermal plasmas; microorganisms, fungi, plants, insects, animals, and humans; and antioxidant enzymes, pathways, and networks. We welcome both full-length and short Research Communications, Hypothesis Papers, Reviews, Mini Reviews, Graphical Reviews, and Critical Methods Papers. Free Radical Biology and Medicine also commissions themed Special Issues aimed at highlighting recent advances in both basic and clinical fields, with a particular focus on mechanisms underlying altered metabolism and redox signalling.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Ethnopharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Principles of pharmacology

Psychoneuropharmacology

Pulmonary pharmacology

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health